However, the change in serum CK activity is not necessarily consistent with CK overexpression in the tumor tissue; for example, elevated CKB levels in tumor cytosol and low total serum CK activity were reported in breast cancer patients [14, 15]. This evidence concerns the gene CKB and neoplasm.